Kidney transplantation is considered the favored treatment for patients suffering from end-
stage renal disease, since successful transplantation is associated with longer survival and …

Renal transplantation is currently the treatment of choice for end-stage kidney disease,
enabling a quality of life superior to dialysis. Despite this, all transplanted patients are at risk …

Acute renal allograft rejection (ARAR) after kidney transplantation associated with reduced
graft survival and eventual graft failure is poorly diagnosed in hospitals. Here, we report the …

Patient monitoring after kidney transplantation (KT) for early detection of allograft rejection
remains key in preventing allograft loss. Serum creatinine has poor predictive value to detect …

Despite new advancements in surgical tools and therapies, exposure to immunosuppressive
drugs related to non-immune and immune injuries can cause slow deterioration and …

Non-invasive technologies to monitor kidney allograft health utilizing high-throughput
assays of blood and urine specimens are emerging out of the research realm and slowly …

Background Non-invasive biomarkers of graft rejection are needed to optimize the
management and outcomes of kidney transplant recipients. Urinary excretion of IFN-γ …

Urinary CXCL10 and metabolites are biomarkers independently associated with TCMR. We
sought to test whether these biomarkers fluctuate in association with histological severity of …

Subclinical kidney allograft acute rejection (SCR) corresponds to “the unexpected
histological evidence of acute rejection in a stable patient.” SCR detection relies on …

Urinary levels of CCL2 and CXCL10 chemokines as potential biomarkers of ongoing
pathological processes in kidney allograft: an Page 1 POLISH ARCHIVES OF INTERNAL …